News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
167,621 Results
Type
Article (12837)
Company Profile (55)
Press Release (154727)
Multimedia
Podcasts (43)
Webinars (9)
Section
Business (49590)
Career Advice (1408)
Deals (7554)
Drug Delivery (47)
Drug Development (22283)
Employer Resources (93)
FDA (4223)
Job Trends (4452)
News (83315)
Policy (7222)
Tag
Academia (828)
Accelerated approval (8)
Adcomms (3)
Allergies (60)
Alliances (9831)
ALS (66)
Alzheimer's disease (560)
Antibody-drug conjugate (ADC) (127)
Approvals (4348)
Artificial intelligence (259)
Autoimmune disease (58)
Automation (18)
Bankruptcy (56)
Best Places to Work (3780)
BIOSECURE Act (12)
Biosimilars (82)
Biotechnology (31)
Bladder cancer (80)
Brain cancer (21)
Breast cancer (298)
Cancer (2124)
Cardiovascular disease (162)
Career advice (1190)
Career pathing (31)
CAR-T (120)
CDC (48)
Cell therapy (329)
Cervical cancer (19)
Clinical research (20518)
Collaboration (713)
Compensation (486)
Complete response letters (12)
COVID-19 (894)
CRISPR (42)
C-suite (338)
Cystic fibrosis (77)
Data (2658)
Decentralized trials (1)
Denatured (2)
Depression (50)
Diabetes (179)
Diagnostics (1813)
Digital health (20)
Diversity (4)
Diversity, equity & inclusion (22)
Drug discovery (104)
Drug pricing (84)
Drug shortages (14)
Duchenne muscular dystrophy (114)
Earnings (25352)
Editorial (36)
Employer branding (10)
Employer resources (83)
Events (23115)
Executive appointments (504)
FDA (5553)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (732)
Gene editing (98)
Generative AI (23)
Gene therapy (261)
GLP-1 (391)
Government (1462)
Grass and pollen (7)
Guidances (228)
Healthcare (4989)
HIV (34)
Huntington's disease (16)
IgA nephropathy (26)
Immunology and inflammation (100)
Immuno-oncology (15)
Indications (42)
Infectious disease (1024)
Inflammatory bowel disease (72)
Inflation Reduction Act (7)
Influenza (47)
Intellectual property (66)
Interviews (248)
IPO (4337)
IRA (19)
Job creations (921)
Job search strategy (979)
Kidney cancer (6)
Labor market (47)
Layoffs (201)
Leadership (27)
Legal (1144)
Liver cancer (40)
Longevity (6)
Lung cancer (305)
Lymphoma (182)
Machine learning (18)
Management (34)
Manufacturing (301)
MASH (109)
Medical device (3584)
Medtech (3593)
Mergers & acquisitions (3704)
Metabolic disorders (513)
Multiple sclerosis (78)
NASH (9)
Neurodegenerative disease (135)
Neuropsychiatric disorders (25)
Neuroscience (1042)
NextGen: Class of 2025 (2011)
Non-profit (1396)
Now hiring (10)
Obesity (223)
Opinion (171)
Ovarian cancer (65)
Pain (55)
Pancreatic cancer (82)
Parkinson's disease (96)
Partnered (15)
Patents (143)
Patient recruitment (161)
Peanut (26)
People (13980)
Pharmaceutical (12)
Pharmacy benefit managers (14)
Phase I (6000)
Phase II (8623)
Phase III (7651)
Pipeline (1804)
Policy (167)
Postmarket research (820)
Preclinical (1916)
Press Release (12)
Prostate cancer (125)
Psychedelics (18)
Radiopharmaceuticals (87)
Rare diseases (367)
Real estate (1526)
Recruiting (41)
Regulatory (6244)
Reports (14)
Research institute (734)
Resumes & cover letters (238)
Rett syndrome (15)
RNA editing (9)
RSV (42)
Schizophrenia (56)
Series A (132)
Series B (97)
Service/supplier (4)
Sickle cell disease (56)
Special edition (11)
Spinal muscular atrophy (51)
Sponsored (29)
Startups (1758)
Stomach cancer (3)
Supply chain (48)
Tariffs (44)
The Weekly (40)
Vaccines (458)
Venture capital (54)
Weight loss (151)
Women's health (31)
Worklife (16)
Date
Today (3)
Last 7 days (296)
Last 30 days (1011)
Last 365 days (14505)
2025 (14107)
2024 (11938)
2023 (11320)
2022 (13834)
2021 (14428)
2020 (14148)
2019 (12281)
2018 (8922)
2017 (8397)
2016 (7780)
2015 (8583)
2014 (5971)
2013 (4450)
2012 (4769)
2011 (5024)
2010 (3913)
Location
Africa (327)
Alabama (19)
Alaska (1)
Arizona (62)
Arkansas (5)
Asia (13575)
Australia (2038)
California (4719)
Canada (1045)
China (388)
Colorado (203)
Connecticut (207)
Delaware (202)
Europe (29890)
Florida (500)
Georgia (97)
Hawaii (2)
Idaho (13)
Illinois (366)
India (20)
Indiana (219)
Iowa (11)
Japan (217)
Kansas (19)
Kentucky (12)
Louisiana (10)
Maine (51)
Maryland (485)
Massachusetts (3330)
Michigan (101)
Minnesota (241)
Mississippi (2)
Missouri (55)
Montana (5)
Nebraska (6)
Nevada (54)
New Hampshire (21)
New Jersey (1258)
New Mexico (7)
New York (1184)
North Carolina (495)
North Dakota (2)
Northern California (2236)
Ohio (119)
Oklahoma (9)
Oregon (13)
Pennsylvania (790)
Puerto Rico (5)
Rhode Island (16)
South America (392)
South Carolina (11)
South Dakota (1)
Southern California (1712)
Tennessee (74)
Texas (679)
United States (15737)
Utah (78)
Vermont (1)
Virginia (121)
Washington D.C. (32)
Washington State (311)
West Virginia (4)
Wisconsin (81)
167,621 Results for "f star".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
December 10, 2025
·
3 min read
Press Releases
Star Therapeutics Announces Oversubscribed $125 Million Series D Financing
September 30, 2025
·
5 min read
Press Releases
Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines
November 18, 2025
·
3 min read
Mergers & acquisitions
Genmab Buys Rising Cancer Star Merus for $8B
The centerpiece of the acquisition is petosemtamab, Merus’ bispecific antibody targeting EGFR and LGR5, which in May demonstrated best-in-class potential for head-and-neck cancer.
September 29, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
December 8, 2025
·
6 min read
Press Releases
Medicovestor, Inc. Wins First Place at the Next Star North America Biomedical Special Competition in Boston, part of the 2025 Entrepreneur Next Star Million Prize Global Challenge
September 25, 2025
·
2 min read
Press Releases
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
November 7, 2025
·
9 min read
Press Releases
Star Therapeutics to Present Interim Data from Phase 1/2 Multidose Study of VGA039 in von Willebrand disease at ASH Annual Meeting
November 3, 2025
·
4 min read
Press Releases
Sydnexis Announces Topline Pivotal Data from Phase 3 STAR Trial of SYD-101 for Patients with Pediatric Progressive Myopia Presented at AMCP Nexus 2025
November 5, 2025
·
7 min read
Press Releases
Astria Therapeutics Announces Positive Initial Results from the Phase 1a Healthy Subject Trial of STAR-0310 at the European Academy of Dermatology and Venereology
September 18, 2025
·
9 min read
1 of 16,763
Next
